NCT02297854View on ClinicalTrials.gov

Bioavailability Study of Valganciclovir Hydrochloride Tablets 450 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy
Interventions
DRUG

Valganciclovir Hydrochloride

Valganciclovir Hydrochloride Tablets 450 mg

Trial Locations (1)

380 061

Lambda Therapeutic Research Ltd, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY